Pharmacy · FR · Founded 2017 · Accounts through 2021 · Updated Jul 27, 2026
No public value estimate is available for this company yet. Review the registered details, express interest or claim the profile as the owner.
Is this your company? Claim and manage this profile
SELAS PHARMACIE DES QUATRE COMMUNES has public figures, but the legal status or filing freshness makes an automated going-concern multiple misleading. Verify current continuity and owner context before showing a range.
Create a free account to add verified turnover, normalised EBITDA, debt and one-offs for SELAS PHARMACIE DES QUATRE COMMUNES in a private workspace.
We keep this public page conservative, so weak filings never become a false price.The page can still show filed facts, but the automatic public range is blocked when those facts would make the multiple misleading.
Operating as a pharmacy, SELAS PHARMACIE DES QUATRE COMMUNES is registered in France. The company was founded in 2017.
SELAS PHARMACIE DES QUATRE COMMUNES is listed in French National Business Register (RNE/INPI) under registry number 830142618. The public employee band is 00, a useful triage field for banks, credit analysts, and M&A acquirers. This profile consolidates official annual accounts into one indexable company dossier.
Companies in this NACE 47.73 band file annual accounts with INPI.
The most recent annual filing covers 2021 (period end 2021-12-31).
This page is refreshed whenever new regulator-filed data for SELAS PHARMACIE DES QUATRE COMMUNES becomes available, consolidated into a single audit-grade view.
Register your interest privately. Upswitch reviews every request and keeps it queued until a safe, verified owner contact route is available.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Claim this companyPublic regulator-filed figures across 6 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202331 Dec 2023 | - | - | €1,211,312 | €960,851 | - |
| 202231 Dec 2022 | - | - | €2,576,471 | €852,144 | - |
| 202131 Dec 2021 | €2,090,293 | - | €2,632,009 | €666,955 | - |
| 202031 Mar 2020 | €2,715,136 | - | €2,409,037 | €368,251 | - |
| 201931 Mar 2019 | €2,585,780 | - | €2,612,884 | €190,608 | - |
| 201831 Mar 2018 | €1,858,290 | - | €2,710,767 | €35,266 | - |
SELAS PHARMACIE DES QUATRE COMMUNES was founded in 2017 and is registered with French National Business Register (RNE/INPI).
SELAS PHARMACIE DES QUATRE COMMUNES is registered under NACE 47.73. That places the business within the French cluster for this activity.
The most recently filed annual accounts cover fiscal year 2021 (period end 2021-12-31), publicly available via French National Business Register (RNE/INPI).
This page shows official or licensed public company facts and valuation-readiness context for SELAS PHARMACIE DES QUATRE COMMUNES; it does not show an automated public valuation range. The available facts may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
Indicative public valuation range based on financial year 2023. This historical record does not yet contain an immutable calculation snapshot, so no sector range is reconstructed after the fact. Not a transaction value, asking price or fairness opinion.
